헬스케어 분석 검사 서비스 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문별 예측(2025-2030년)

Healthcare Analytical Testing Services Market Growth & Trends:

The global healthcare analytical testing services market size is anticipated to reach USD 25.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.41% from 2025 to 2030. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines' approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services. As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights:

• The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth.
• The Pharmaceutical Analytical Testing Services market held the largest market share of 58.3% in 2024.
• North America dominated the global market with the largest revenue share of 38.49% in 2024 owing to the presence of the largest clinical trials market in the U.S.
• The Asia Pacific region is anticipated to grow at the fastest CAGR of 8.92% during the forecast period.
• This growth can be credited to the development and expansion of new facilities in different countries present in this region.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL by SWOT Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis

• 4.1. Healthcare Analytical Testing Services Market, By Type: Segment Dashboard
• 4.2. Healthcare Analytical Testing Services Market, By Type: Movement Analysis
• 4.3. Healthcare Analytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030
• 4.4. Medical Device Analytical Testing Services
  • 4.4.1. Medical Device Analytical Testing Services Market, 2018 to 2030 (USD Million)
  • 4.4.2. Extractable and Leachable
    • 4.4.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
  • 4.4.3. Material Characterization
    • 4.4.3.1. Material Characterization Market, 2018 to 2030 (USD Million)
  • 4.4.4. Physical Testing
    • 4.4.4.1. Physical Testing Market, 2018 to 2030 (USD Million)
  • 4.4.5. Bioburden Testing
    • 4.4.5.1. Bioburden Testing Market, 2018 to 2030 (USD Million)
  • 4.4.6. Sterility Testing
    • 4.4.6.1. Sterility Testing Market, 2018 to 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others Market, 2018 to 2030 (USD Million)
• 4.5. Pharmaceutical Analytical Testing Services
  • 4.5.1. Pharmaceutical Analytical Testing Services Market, 2018 to 2030 (USD Million)
  • 4.5.2. Bioanalytical Testing
    • 4.5.2.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
  • 4.5.3. Method Development and Validation
    • 4.5.3.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
  • 4.5.4. Stability Testing
    • 4.5.4.1. Stability Testing Market, 2018 to 2030 (USD Million)
  • 4.5.5. Other Testing Services
    • 4.5.5.1. Other Testing Services Market, 2018 to 2030 (USD Million)

Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Global Regional Market Snapshot
• 5.4. North America
  • 5.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. U.S.
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Competitive Scenario
    • 5.4.2.3. Regulatory Framework
    • 5.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Canada
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Competitive Scenario
    • 5.4.3.3. Regulatory Framework
    • 5.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Mexico
    • 5.4.4.1. Key Country Dynamics
    • 5.4.4.2. Competitive Scenario
    • 5.4.4.3. Regulatory Framework
    • 5.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Competitive Scenario
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Competitive Scenario
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Competitive Scenario
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Competitive Scenario
    • 5.5.5.3. Regulatory Framework
    • 5.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.6. Spain
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Competitive Scenario
    • 5.5.6.3. Regulatory Framework
    • 5.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.7. Sweden
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Competitive Scenario
    • 5.5.7.3. Regulatory Framework
    • 5.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.8. Denmark
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Competitive Scenario
    • 5.5.8.3. Regulatory Framework
    • 5.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.9. Norway
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Competitive Scenario
    • 5.5.9.3. Regulatory Framework
    • 5.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Competitive Scenario
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Competitive Scenario
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Competitive Scenario
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. Thailand
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Competitive Scenario
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. South Korea
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Competitive Scenario
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Australia
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Competitive Scenario
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Competitive Scenario
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Competitive Scenario
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. MEA
  • 5.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Competitive Scenario
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Competitive Scenario
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Competitive Scenario
    • 5.8.4.3. Regulatory Framework
    • 5.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Competitive Scenario
    • 5.8.5.3. Regulatory Framework
    • 5.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
  • 6.1.1. Market Leaders
  • 6.1.2. Emerging Players
• 6.2. Company Market Share/Assessment Analysis, 2024
• 6.3. Company Profiles
  • 6.3.1. Thermo Fisher Scientific, Inc.
    • 6.3.1.1. Company Overview
    • 6.3.1.2. Financial Performance
    • 6.3.1.3. Service Benchmarking
    • 6.3.1.4. Strategic Initiatives
  • 6.3.2. ICON plc
    • 6.3.2.1. Company Overview
    • 6.3.2.2. Financial Performance
    • 6.3.2.3. Service Benchmarking
    • 6.3.2.4. Strategic Initiatives
  • 6.3.3. LabCorp
    • 6.3.3.1. Company Overview
    • 6.3.3.2. Financial Performance
    • 6.3.3.3. Service Benchmarking
    • 6.3.3.4. Strategic Initiatives
  • 6.3.4. Charles River Laboratories International, Inc.
    • 6.3.4.1. Company Overview
    • 6.3.4.2. Financial Performance
    • 6.3.4.3. Service Benchmarking
    • 6.3.4.4. Strategic Initiatives
  • 6.3.5. Syneos Health
    • 6.3.5.1. Company Overview
    • 6.3.5.2. Financial Performance
    • 6.3.5.3. Service Benchmarking
    • 6.3.5.4. Strategic Initiatives
  • 6.3.6. SGS SA
    • 6.3.6.1. Company Overview
    • 6.3.6.2. Financial Performance
    • 6.3.6.3. Service Benchmarking
    • 6.3.6.4. Strategic Initiatives
  • 6.3.7. Eurofins Scientific
    • 6.3.7.1. Company Overview
    • 6.3.7.2. Financial Performance
    • 6.3.7.3. Service Benchmarking
    • 6.3.7.4. Strategic Initiatives
  • 6.3.8. Pace Analytical Services, LLC
    • 6.3.8.1. Company Overview
    • 6.3.8.2. Financial Performance
    • 6.3.8.3. Service Benchmarking
    • 6.3.8.4. Strategic Initiatives
  • 6.3.9. Toxikon, Inc.
    • 6.3.9.1. Company Overview
    • 6.3.9.2. Financial Performance
    • 6.3.9.3. Service Benchmarking
    • 6.3.9.4. Strategic Initiatives
  • 6.3.10. Intertek Group
    • 6.3.10.1. Company Overview
    • 6.3.10.2. Financial Performance
    • 6.3.10.3. Service Benchmarking
    • 6.3.10.4. Strategic Initiatives